Treatment of liver-limited metastatic colorectal cancer

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Although liver metastases from colorectal cancer previously conferred a very dismal prognosis, advances in systemic therapy combined with surgical techniques now gives these patients a reasonable chance for cure. Traditional cytoxic chemotherapy combined with biologic agents result in impressive response rates, allowing a portion of patients who were considered unresectable to undergo hepatectomy with curative intent. This review discusses the role of systemic therapy in patients with liver-limited metastatic disease for patients with resectable, potentially resectable and unresectable disease.

Original languageEnglish (US)
Pages (from-to)235-240
Number of pages6
JournalCancer Journal
Issue number3
StatePublished - May 1 2010


  • Adjuvant chemotherapy
  • Colorectal liver metastases
  • Liver neoplasms
  • Neoadjuvant chemotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Treatment of liver-limited metastatic colorectal cancer'. Together they form a unique fingerprint.

Cite this